The Association Between Vitamin D and Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease: An Observational Cross-Sectional Study

References

• Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43(2 Suppl 1):S99–s112. doi:10.1002/hep.20973
   PubMed Web of Science ®Google Scholar
• Younossi ZM, Golabi P, de Avila L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71(4):793–801. doi:10.1016/j.jhep.2019.06.021
   PubMed Web of Science ®Google Scholar
• Amiri Dash Atan N, Koushki M, Motedayen M, et al. Type 2 diabetes mellitus and non-alcoholic fatty liver disease: a systematic review and meta-analysis. Gastroenterol Hepatol Bed Bench. 2017;10(Suppl1):S1–s7.
   Google Scholar
• Dai W, Ye L, Liu A, et al. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a meta-analysis. Medicine. 2017;96(39):e8179. doi:10.1097/MD.0000000000008179
   PubMed Web of Science ®Google Scholar
• Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Am J Gastroenterol. 2012;107(6):811–826. doi:10.1038/ajg.2012.128
   PubMed Web of Science ®Google Scholar
• Mikolasevic I, Milic S, Turk Wensveen T, et al. Nonalcoholic fatty liver disease - A multisystem disease? World J Gastroenterol. 2016;22(43):9488–9505. doi:10.3748/wjg.v22.i43.9488
   Web of Science ®Google Scholar
• Barchetta I, Del Ben M, Angelico F, et al. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. BMC Med. 2016;14:92. doi:10.1186/s12916-016-0638-y
   PubMed Web of Science ®Google Scholar
• Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev. 2016;96(1):365–408. doi:10.1152/physrev.00014.2015
   PubMed Web of Science ®Google Scholar
• Tsuprykov O, Chen X, Hocher CF, Skoblo R, Lianghong Y, Hocher B. Why should we measure free 25(OH) vitamin D? J Steroid Biochem Mol Biol. 2018;180:87–104. doi:10.1016/j.jsbmb.2017.11.014
   PubMed Web of Science ®Google Scholar
• Pham H, Waterhouse M, Baxter C, et al. The effect of vitamin D supplementation on acute respiratory tract infection in older Australian adults: an analysis of data from the D-Health Trial. Lancet Diabetes Endocrinol. 2021;9(2):69–81. doi:10.1016/S2213-8587(20)30380-6
   PubMed Web of Science ®Google Scholar
• Gagnon C, Lu ZX, Magliano DJ, et al. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: ausDiab). J Clin Endocrinol Metab. 2012;97(6):1953–1961. doi:10.1210/jc.2011-3187
   PubMed Web of Science ®Google Scholar
• Lips P, Eekhoff M, van Schoor N, et al. Vitamin D and type 2 diabetes. J Steroid Biochem Mol Biol. 2017;173:280–285. doi:10.1016/j.jsbmb.2016.11.021
   PubMed Web of Science ®Google Scholar
• Sacerdote A, Dave P, Lokshin V, Bahtiyar G. Type 2 diabetes mellitus, insulin resistance, and Vitamin D. Curr Diab Rep. 2019;19(10):101. doi:10.1007/s11892-019-1201-y
   PubMed Web of Science ®Google Scholar
• Rhee EJ, Kim MK, Park SE, et al. High serum vitamin D levels reduce the risk for nonalcoholic fatty liver disease in healthy men independent of metabolic syndrome. Endocr J. 2013;60(6):743–752. doi:10.1507/endocrj.EJ12-0387
   PubMed Web of Science ®Google Scholar
• Manson JE, Cook NR, Lee IM, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380(1):33–44. doi:10.1056/NEJMoa1809944
   PubMed Web of Science ®Google Scholar
• Pollock RD, Duggal NA, Lazarus NR, Lord JM, Harridge SDR. Cardiorespiratory fitness not sedentary time or physical activity is associated with cardiometabolic risk in active older adults. Scand J Med Sci Sports. 2018;28(6):1653–1660. doi:10.1111/sms.13071
   Web of Science ®Google Scholar
• Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. 2017;18(2):153–165. doi:10.1007/s11154-017-9424-1
   PubMed Web of Science ®Google Scholar
• Jiang Z, Pu R, Li N, et al. High prevalence of vitamin D deficiency in Asia: a systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2021;1–10. doi:10.1080/10408398.2021.1990850
   Web of Science ®Google Scholar
• Dasarathy J, Periyalwar P, Allampati S, et al. Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease. Liver Int. 2014;34(6):e118–127. doi:10.1111/liv.12312
   PubMed Web of Science ®Google Scholar
• Eliades M, Spyrou E, Agrawal N, et al. Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2013;38(3):246–254. doi:10.1111/apt.12377
   PubMed Web of Science ®Google Scholar
• Găman MA, Dobrică EC, Cozma MA, et al. Crosstalk of magnesium and serum lipids in dyslipidemia and associated disorders: a systematic review. Nutrients. 2021;13(5):1411. doi:10.3390/nu13051411
   PubMed Web of Science ®Google Scholar
• Sohouli MH, Sayyari AA, Lari A, et al. Association of dietary insulinaemic potential and odds of non-alcoholic fatty liver disease among adults: a case-control study. J Hum Nutr Diet. 2021;34(5):901–909. doi:10.1111/jhn.12865
   Web of Science ®Google Scholar
• Lonardo A, Nascimbeni F, Mantovani A, Targher G. Hypertension, diabetes, atherosclerosis and NASH: cause or consequence? J Hepatol. 2018;68(2):335–352. doi:10.1016/j.jhep.2017.09.021
   PubMed Web of Science ®Google Scholar
• Loomba R, Abraham M, Unalp A, et al. Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology. 2012;56(3):943–951. doi:10.1002/hep.25772
   PubMed Web of Science ®Google Scholar
• Li Y, Wang J, Tang Y, et al. Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: evidence from the Dongfeng-Tongji cohort study. PLoS One. 2017;12(3):e0174291. doi:10.1371/journal.pone.0174291
   PubMed Web of Science ®Google Scholar
• Bril F, Cusi K. Nonalcoholic fatty liver disease: the new complication of type 2 diabetes mellitus. Endocrinol Metab Clin North Am. 2016;45(4):765–781. doi:10.1016/j.ecl.2016.06.005
   PubMed Web of Science ®Google Scholar
• Fukuda T, Hamaguchi M, Kojima T, et al. Transient remission of nonalcoholic fatty liver disease decreases the risk of incident type 2 diabetes mellitus in Japanese men. Eur J Gastroenterol Hepatol. 2016;28(12):1443–1449. doi:10.1097/MEG.0000000000000736
   PubMed Web of Science ®Google Scholar
• Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007;102(12):2708–2715. doi:10.1111/j.1572-0241.2007.01526.x
   PubMed Web of Science ®Google Scholar
• Xiu L, Jiang T, Yao XA, Wen Z. Correlation between 25 Hydroxyvitamin D levels and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus: a cross-sectional study. Int J Gen Med. 2021;14:3099–3107. doi:10.2147/IJGM.S319449
   Web of Science ®Google Scholar
• Bourbour F, Kabir A, Pazouki A, et al. Trends in serum Vitamin D levels within 12 months after One Anastomosis Gastric Bypass (OAGB). Obes Surg. 2021;31(9):3956–3965. doi:10.1007/s11695-021-05434-6
   Web of Science ®Google Scholar
• Wei Q, Xu X, Guo L, Li J, Li L. Effect of SGLT2 inhibitors on type 2 diabetes mellitus with non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. Front Endocrinol. 2021;12:635556. doi:10.3389/fendo.2021.635556
   PubMed Web of Science ®Google Scholar
• Lian J, Fu J. Pioglitazone for NAFLD patients with prediabetes or type 2 diabetes mellitus: a meta-analysis. Front Endocrinol. 2021;12:615409. doi:10.3389/fendo.2021.615409
   PubMed Web of Science ®Google Scholar
• Bjelakovic G, Nikolova D, Bjelakovic M, Gluud C. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database Syst Rev. 2017;11(11):Cd011564. doi:10.1002/14651858.CD011564.pub2
   PubMed Web of Science ®Google Scholar
• Hosny SS, Ali HM, Mohammed WA, El Ghannam MH. Study of relationship between total vitamin D level and NAFLD in a sample of Egyptian patients with and without T2DM. Diabetes Metab Syndr. 2019;13(3):1769–1771. doi:10.1016/j.dsx.2019.04.002
   Web of Science ®Google Scholar
• Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690–693. doi:10.1093/ajcn/72.3.690
   PubMed Web of Science ®Google Scholar
• Flegal KM, Shepherd JA, Looker AC, et al. Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr. 2009;89(2):500–508. doi:10.3945/ajcn.2008.26847
   PubMed Web of Science ®Google Scholar
• Caleyachetty R, Barber TM, Mohammed NI, et al. Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2021;9(7):419–426. doi:10.1016/S2213-8587(21)00088-7
   PubMed Web of Science ®Google Scholar
• Teufel F, Seiglie JA, Geldsetzer P, et al. Body-mass index and diabetes risk in 57 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 685 616 adults. Lancet. 2021;398(10296):238–248. doi:10.1016/S0140-6736(21)00844-8
   Web of Science ®Google Scholar
• Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020;369:m997. doi:10.1136/bmj.m997
   PubMed Web of Science ®Google Scholar
• Wang L, Zhou B, Zhao Z, et al. Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004–18. Lancet. 2021;398(10294):53–63. doi:10.1016/S0140-6736(21)00798-4
   PubMed Web of Science ®Google Scholar
• Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 2021;9(6):373–392. doi:10.1016/S2213-8587(21)00045-0
   PubMed Web of Science ®Google Scholar
• Wang Q, Shi X, Wang J, Zhang J, Xu C. Low serum vitamin D concentrations are associated with obese but not lean NAFLD: a cross-sectional study. Nutr J. 2021;20(1):30. doi:10.1186/s12937-021-00690-9
   Web of Science ®Google Scholar
• Barchetta I, Angelico F, Del Ben M, et al. Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med. 2011;9:85. doi:10.1186/1741-7015-9-85
   PubMed Web of Science ®Google Scholar
• Seo JA, Eun CR, Cho H, et al. Low vitamin D status is associated with nonalcoholic Fatty liver disease independent of visceral obesity in Korean adults. PLoS One. 2013;8(10):e75197. doi:10.1371/journal.pone.0075197
   Web of Science ®Google Scholar
• Nelson JE, Roth CL, Wilson LA, et al. Vitamin D deficiency is associated with increased risk of non-alcoholic steatohepatitis in adults with non-alcoholic fatty liver disease: possible role for MAPK and NF-κB? Am J Gastroenterol. 2016;111(6):852–863. doi:10.1038/ajg.2016.51
   PubMed Web of Science ®Google Scholar
• Farhangi MA, Mesgari-Abbasi M, Hajiluian G, Nameni G, Shahabi P. Adipose tissue inflammation and oxidative stress: the ameliorative effects of Vitamin D. Inflammation. 2017;40(5):1688–1697. doi:10.1007/s10753-017-0610-9
   Web of Science ®Google Scholar
• Asemi Z, Hashemi T, Karamali M, Samimi M, Esmaillzadeh A. Effects of vitamin D supplementation on glucose metabolism, lipid concentrations, inflammation, and oxidative stress in gestational diabetes: a double-blind randomized controlled clinical trial. Am J Clin Nutr. 2013;98(6):1425–1432. doi:10.3945/ajcn.113.072785
   PubMed Web of Science ®Google Scholar
• Mohammadi SM, Eghbali SA, Soheilikhah S, et al. The effects of vitamin D supplementation on adiponectin level and insulin resistance in first-degree relatives of subjects with type 2 diabetes: a randomized double-blinded controlled trial. Electron Phy. 2016;8(9):2849–2854. doi:10.19082/2849
   Google Scholar
• Mutt SJ, Hyppönen E, Saarnio J, Järvelin MR, Herzig KH. Vitamin D and adipose tissue-more than storage. Front Physiol. 2014;5:228. doi:10.3389/fphys.2014.00228
   PubMed Web of Science ®Google Scholar
• Alhabeeb H, Kord-Varkaneh H, Tan SC, et al. The influence of omega-3 supplementation on vitamin D levels in humans: a systematic review and dose-response meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr. 2020;1–8. doi:10.1080/10408398.2020.1863905
   Web of Science ®Google Scholar
• Talaei A, Mohamadi M, Adgi Z. The effect of vitamin D on insulin resistance in patients with type 2 diabetes. Diabetol Metab Syndr. 2013;5(1):8. doi:10.1186/1758-5996-5-8
   Web of Science ®Google Scholar
• Papapostoli I, Lammert F, Stokes CS. Effect of short-term Vitamin D correction on hepatic steatosis as quantified by controlled attenuation parameter (CAP). J Gastrointestin Liver Dis. 2016;25(2):175–181. doi:10.15403/jgld.2014.1121.252.cap
   PubMed Web of Science ®Google Scholar
• Heaney RP. Vitamin D–baseline status and effective dose. N Engl J Med. 2012;367(1):77–78. doi:10.1056/NEJMe1206858
   PubMed Web of Science ®Google Scholar
• Rezaei S, Tabrizi R, Nowrouzi-Sohrabi P, et al. The effects of Vitamin D supplementation on anthropometric and biochemical indices in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. Front Pharmacol. 2021;12:732496. doi:10.3389/fphar.2021.732496
   PubMed Web of Science ®Google Scholar
• Gheorghe G, Bungău S, Ceobanu G, et al. The non-invasive assessment of hepatic fibrosis. J Formos Med Assoc. 2021;120(2):794–803. doi:10.1016/j.jfma.2020.08.019
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiang X, Li X, et al. Serum Vitamin D levels and risk of liver cancer: a systematic review and dose-response meta-analysis of cohort studies. Nutr Cancer. 2021;73(8):1–9. doi:10.1080/01635581.2020.1797127
   PubMed Web of Science ®Google Scholar
• Benedict M, Zhang X. Non-alcoholic fatty liver disease: an expanded review. World J Hepatol. 2017;9(16):715–732. doi:10.4254/wjh.v9.i16.715
   PubMed Web of Science ®Google Scholar
• Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology. 1998;114(4):842–845. doi:10.1016/S0016-5085(98)70599-2
   PubMed Web of Science ®Google Scholar
• Zhou QG, Hou FF, Guo ZJ, Liang M, Wang GB, Zhang X. 1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells. Diabetes Metab Res Rev. 2008;24(6):459–464. doi:10.1002/dmrr.873
   PubMed Web of Science ®Google Scholar
• Maia-Ceciliano TC, Dutra RR, Aguila MB, Mandarim-de-lacerda CA. The deficiency and the supplementation of vitamin D and liver: lessons of chronic fructose-rich diet in mice. J Steroid Biochem Mol Biol. 2019;192:105399. doi:10.1016/j.jsbmb.2019.105399
   Web of Science ®Google Scholar
• Tamadon MR, Soleimani A, Keneshlou F, et al. Clinical trial on the effects of Vitamin D supplementation on metabolic profiles in diabetic hemodialysis. Horm Metab Res. 2018;50(1):50–55. doi:10.1055/s-0043-119221
   Web of Science ®Google Scholar
• Tarcin O, Yavuz DG, Ozben B, et al. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J Clin Endocrinol Metab. 2009;94(10):4023–4030. doi:10.1210/jc.2008-1212
   PubMed Web of Science ®Google Scholar
• Eftekhari MH, Akbarzadeh M, Dabbaghmanesh MH, Hassanzadeh J. The effect of calcitriol on lipid profile and oxidative stress in hyperlipidemic patients with type 2 diabetes mellitus. ARYA Atheroscler. 2014;10(2):82–88.
   Google Scholar
• Nakano T, Cheng YF, Lai CY, et al. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats. J Hepatol. 2011;55(2):415–425. doi:10.1016/j.jhep.2010.11.028
   PubMed Web of Science ®Google Scholar
• Caldwell SH, Argo CK. Divergent effects of peroxisome proliferator-activated receptor-gamma ligands in human and mouse nonalcoholic steatohepatitis. Hepatology. 2007;46(2):285–287. doi:10.1002/hep.21881
   Web of Science ®Google Scholar
• Haussler MR, Haussler CA, Bartik L, et al. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev. 2008;66(10 Suppl 2):S98–112. doi:10.1111/j.1753-4887.2008.00093.x
   PubMed Web of Science ®Google Scholar
• Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care. 2005;28(5):1228–1230. doi:10.2337/diacare.28.5.1228
   PubMed Web of Science ®Google Scholar
• Abenavoli L, Milic N, Di Renzo L, Preveden T, Medić-Stojanoska M, De Lorenzo A. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World j Gastroenterol. 2016;22(31):7006–7016. doi:10.3748/wjg.v22.i31.7006
   PubMed Web of Science ®Google Scholar
• Kong M, Zhu L, Bai L, et al. Vitamin D deficiency promotes nonalcoholic steatohepatitis through impaired enterohepatic circulation in animal model. Am J Physiol Gastrointest Liver Physiol. 2014;307(9):G883–893. doi:10.1152/ajpgi.00427.2013
   Web of Science ®Google Scholar
• Ebrahimzadeh Leylabadlo H, Samadi Kafil H, Farajnia S, et al. Gut microbiota in nonalcoholic fatty liver diseases with and without type-2 diabetes mellitus. Eur J Gastroenterol Hepatol. 2021;33:e548–e554. doi:10.1097/MEG.0000000000002140
   PubMed Web of Science ®Google Scholar